207 related articles for article (PubMed ID: 17440973)
1. PIAS1 interacts with and represses SOX9 transactivation activity.
Oh HJ; Kido T; Lau YF
Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
5. Repression of E1AF transcriptional activity by sumoylation and PIASy.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction of AIRE with PIAS1 in transcriptional regulation.
Ilmarinen T; Kangas H; Kytömaa T; Eskelin P; Saharinen J; Seeler JS; Tanhuanpää K; Chan FY; Slattery RM; Alakurtti K; Palvimo JJ; Ulmanen I
Mol Immunol; 2008 Apr; 45(7):1847-62. PubMed ID: 18083234
[TBL] [Abstract][Full Text] [Related]
7. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
[TBL] [Abstract][Full Text] [Related]
8. Sox9 transactivation and testicular expression of a novel human gene, KIAA0800.
Zhao LJ; Zhang S; Chinnadurai G
J Cell Biochem; 2002; 86(2):277-89. PubMed ID: 12111997
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net.
Wasylyk C; Criqui-Filipe P; Wasylyk B
Oncogene; 2005 Jan; 24(5):820-8. PubMed ID: 15580297
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human Sox9 promoter by the CCAAT-binding factor.
Colter DC; Piera-Velazquez S; Hawkins DF; Whitecavage MK; Jimenez SA; Stokes DG
Matrix Biol; 2005 May; 24(3):185-97. PubMed ID: 15908194
[TBL] [Abstract][Full Text] [Related]
12. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.
Hattori T; Eberspaecher H; Lu J; Zhang R; Nishida T; Kahyo T; Yasuda H; de Crombrugghe B
J Biol Chem; 2006 May; 281(20):14417-28. PubMed ID: 16554309
[TBL] [Abstract][Full Text] [Related]
13. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
15. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.
Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E
Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788
[TBL] [Abstract][Full Text] [Related]
16. The porcine SRY promoter is transactivated within a male genital ridge environment.
Daneau I; Pilon N; Boyer A; Behdjani R; Overbeek PA; Viger R; Lussier J; Silversides DW
Genesis; 2002 Aug; 33(4):170-80. PubMed ID: 12203914
[TBL] [Abstract][Full Text] [Related]
17. Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model.
Campbell SE; Bennett D; Nasir L; Gault EA; Argyle DJ
Rheumatology (Oxford); 2005 Jun; 44(6):735-43. PubMed ID: 15757961
[TBL] [Abstract][Full Text] [Related]
18. Sox9 is required for notochord maintenance in mice.
Barrionuevo F; Taketo MM; Scherer G; Kispert A
Dev Biol; 2006 Jul; 295(1):128-40. PubMed ID: 16678811
[TBL] [Abstract][Full Text] [Related]
19. Sumoylation of Rta of Epstein-Barr virus is preferentially enhanced by PIASxbeta.
Liu ST; Wang WH; Hong YR; Chuang JY; Lu PJ; Chang LK
Virus Res; 2006 Aug; 119(2):163-70. PubMed ID: 16460827
[TBL] [Abstract][Full Text] [Related]
20. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.
Jacobs AM; Nicol SM; Hislop RG; Jaffray EG; Hay RT; Fuller-Pace FV
Oncogene; 2007 Aug; 26(40):5866-76. PubMed ID: 17369852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
